A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation

Published:2019-02 Issue:2 Volume:25 Page:369-381
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Marty Francisco M.^ORCID,Winston Drew J.,Chemaly Roy F.,Mullane Kathleen M.^ORCID,Shore Tsiporah B.,Papanicolaou Genovefa A.,Chittick Greg,Brundage Thomas M.,Wilson Chad,Morrison Marion E.,Foster Scott A.,Nichols W. Garrett,Boeckh Michael J.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference65 articles.

1. Cytomegalovirus in hematopoietic stem cell transplant recipients: current status, known challenges, and future strategies;Boeckh;Biol Blood Marrow Transplant,2003

2. Cytomegalovirus in hematopoietic stem cell transplant recipients;Ljungman;Infect Dis Clin North Am,2010

3. How we treat cytomegalovirus in hematopoietic cell transplant recipients;Boeckh;Blood,2009

4. Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation;Green;Biol Blood Marrow Transplant,2012

5. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis;Craddock;Br J Haematol,2001

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Treatment efficacy of cidofovir and brincidofovir against clade II Monkeypox virus isolates;Antiviral Research;2024-11

3. UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.;Mediterranean Journal of Hematology and Infectious Diseases;2024-08-31

4. Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation;Viruses;2024-08-08

5. Longitudinal Monitoring of the Effects of Anti-Adenoviral Treatment Regimens in a Permissive In Vivo Model;Viruses;2024-07-26